We structure, lead
and optimise complex regulatory
pathways globally.
Services
We proudly deliver expert regulatory solutions across Europe, Asia, and the Americas, supporting pharmaceutical, biotech and vaccine companies across the full lifecycle of medicinal products in key pharmaceutical markets worldwide – from early development to market access and post‑approval.
We combine strategic insight, hands‑on execution, and global coordination to deliver efficient, compliant and pragmatic regulatory solutions.
Global Regulatory Strategy
& Project Leadership
Regulatory Intelligence
Turning Information into Strategic Advantage
Regulatory success depends on more than understanding requirements. It requires understanding the evolving regulatory landscape, emerging agency expectations, competitor activities, and market dynamics.
At A-REG, we transform publicly available regulatory information into actionable intelligence that supports strategic decision-making. By combining regulatory surveillance, competitor insights, and practical interpretation of emerging requirements, we help clients anticipate challenges, identify opportunities, and make informed decisions throughout the product lifecycle.
Focus areas:
- Regulatory intelligence and surveillance
- Competitor landscape analysis
- Emerging regulatory trends
- Strategic risk identification
- Decision-support insights
Regulatory Strategy
Building the Right Pathway from the Start
Successful regulatory outcomes are rarely achieved by chance. They are the result of deliberate planning, informed decision-making, and timely engagement with Health Authorities.
We work closely with clients to develop tailored regulatory strategies aligned with product objectives, development plans, and commercial goals. From early development through registration and lifecycle management, we evaluate potential pathways, identify risks, and establish clear roadmaps that support efficient and compliant product development.
Focus areas:
- Regulatory pathway design
- Development strategy
- Health Authority engagement planning
- Risk assessment and mitigation
- Global regulatory planning
Regulatory Reliance
Accelerating Global Access Through Regulatory Networks
Regulatory reliance is transforming the way medicinal products reach patients worldwide. Increasingly, Health Authorities leverage assessments and decisions from trusted reference agencies to support faster and more efficient reviews.
A-REG helps clients navigate reliance-based pathways across established and emerging markets. We identify opportunities to maximize existing regulatory approvals, align global submission strategies, and support efficient expansion into new territories while maintaining compliance with local requirements.
Focus areas:
- WHO and international reliance pathways
- Reference authority strategies
- Regional reliance frameworks
- Global submission sequencing
- Market expansion planning
End-to-End Regulatory Support
From Development to Commercialisation and Beyond
Regulatory activities do not occur in isolation. Successful programs require coordination across functions, geographies, stakeholders, and lifecycle phases.
We provide strategic leadership and hands-on execution throughout the entire regulatory journey. Whether supporting a single milestone or leading complex global programs, we help clients navigate regulatory challenges, coordinate activities, and maintain momentum from early development through registration and post-approval lifecycle management.
Focus areas:
- Regulatory program leadership
- Cross-functional coordination
- Submission planning and execution
- Health Authority interactions
- Lifecycle management
Health Authority
Interactions
Navigating Regulatory Dialogue
with Confidence
Successful regulatory interactions require more than scientific expertise. They require careful preparation, strategic positioning, clear communication, and a deep understanding of Health Authority expectations.
At A-REG, we support clients throughout the full spectrum of Health Authority engagements, from early development discussions to pre-submission activities and post-approval interactions. Combining extensive experience with strong advocacy and negotiation skills, we help clients approach each interaction with confidence, clarity, and a well-defined objective.
Scientific Advice
Reducing Uncertainty Before Critical Decisions
Scientific Advice and similar advisory procedures provide valuable opportunities to align development strategies with regulatory expectations before significant investments are made.
We help clients identify key questions, develop robust briefing packages, anticipate potential concerns, and translate Health Authority feedback into practical development strategies. Our goal is to maximise the value of each interaction and reduce regulatory uncertainty before it becomes costly.
Focus areas:
- Scientific Advice preparation
- Briefing package development
- Question strategy and positioning
- Client’s team training and preparation
- Meeting preparation and moderation
- Post-interaction follow up and action planning
Meetings
Turning Discussions into Strategic Outcomes
Health Authority meetings are often pivotal moments in product development and regulatory planning. Success depends on clear objectives, strong messaging, and thorough preparation.
We support clients before, during, and after meetings with agencies worldwide, ensuring discussions remain focused, productive, and aligned with strategic objectives. From scientific discussions to regulatory negotiations, we help clients communicate effectively and confidently.
Focus areas:
- Agency meeting preparation
- Stakeholder alignment
- Presentation development
- Strategic advocacy
- Follow-up and action tracking
Flexibility Requests
Finding the Best Path Forward
Regulatory frameworks provide structure, but successful development programs often require thoughtful discussion on how requirements can be applied to specific product circumstances.
A-REG helps clients explore and justify regulatory flexibilities where scientifically appropriate. We develop evidence-based rationale, assess potential risks, and support constructive dialogue with Health Authorities to identify practical and compliant solutions.
Focus areas:
- Alternative regulatory approaches
- Data package justification
- Procedural flexibility discussions
- Risk-benefit assessments
- Scientific and regulatory rationale development
Health Authority Relationship Management
Building Productive Long-Term Engagement
Regulatory interactions rarely occur in isolation. Long-term success often depends on maintaining continuity, consistency, and constructive relationships throughout the product lifecycle.
We help clients coordinate complex interaction programs, manage communication across multiple agencies, and ensure commitments, timelines, and follow-up activities are effectively tracked and executed. By maintaining a strategic overview, we support productive and professional engagement throughout development, registration, and lifecycle management.
Focus areas:
- Interaction planning and coordination
- Agency communication management
- Global Health Authority engagement and reliance considerations
- Follow-up commitments & lifecycle interaction strategy
- Internal teams training
EMA & MHRA
Deep Expertise in Europe
The Most Complex Regulatory Environment
Whilst A-REG supports regulatory activities globally, our foundations were built within the European regulatory landscape. From centralized EMA procedures to national, decentralized, and mutual recognition pathways, we have spent years helping clients navigate one of the world's most complex regulatory environments.
We understand not only the regulations themselves, but also the practical realities of working across multiple Health Authorities, regulatory systems, and stakeholder groups. This experience allows us to deliver pragmatic guidance, confident execution, and strategic leadership across the European product lifecycle.
EMA & MHRA Regulatory Strategy
Strategic Guidance Across the European Lifecycle
Successful European development and registration programs require more than regulatory compliance. They require a strategy that aligns scientific evidence, procedural requirements, Health Authority expectations, and commercial objectives.
We support clients across all stages of development, registration, and lifecycle management, helping them identify the most appropriate regulatory pathways and navigate critical decision points throughout the product journey.
Focus areas:
- EU’s Centralised Procedure (CP)
- Regulatory Pathways Involving National Health Authorities in Europe (DCP, MRP and/or NP)
- MHRA national and reliance pathways as well as UK lifecycle management
- Regulatory strategy and planning
EMA SME Services
Maximizing the Benefits of EMA SME Status
As an EMA-recognised Small and Medium-sized Enterprise (SME), A-REG understands both the opportunities and administrative requirements associated with the SME framework.
We support eligible companies in evaluating, obtaining, and maintaining EMA SME status while helping them take advantage of available incentives and regulatory support mechanisms.
For emerging biotech and innovative developers, these benefits can contribute meaningfully to long-term regulatory planning and resource optimisation.
Focus areas:
- SME eligibility assessment
- SME registration support
- SME maintenance activities
- Fee reduction opportunities
- Regulatory incentive planning
- EMA SME program guidance
EMA Systems & Digital Readiness
Managing the Regulatory Infrastructure Behind Submissions
Modern regulatory activities increasingly depend on successful navigation of Health Authority digital platforms and supporting processes.
We assist clients with EMA systems, user access management, procedural submissions, and organisational readiness, helping ensure that operational and technical requirements do not become barriers to regulatory success.
Whether clients require targeted support, training, or complete operational outsourcing, we provide practical and scalable solutions tailored to their needs.
Focus areas:
- EMA Account Management, SPOR, IRIS
- EMA Service Desk interactions
- Process development and governance
- Training and operational support
EMA Submission Readiness
Ensuring Organisations Are Ready to File
Successful submissions depend on more than the quality of the dossier. Regulatory procedures, systems, governance, operational planning, and Health Authority requirements must also be aligned before filing.
We help organisations prepare for key pre-submission milestones and identify readiness gaps before they become critical risks.
Focus areas:
- EMA filing overall readiness assessment and risks mitigations
- Eligibility requests, Letter of Intent and other documents preparation
- Product name review procedures management
- Pre-submission planning
- Submission governance
EMA Policy 0070
Transparency, Anonymisation and Redaction Support
Public disclosure requirements continue to play an important role in regulatory transparency. Preparing clinical documents for publication requires careful balancing of transparency obligations, patient privacy, and protection of commercially confidential information.
Our team provides practical support for anonymisation and redaction activities, helping clients prepare compliant documentation while preserving data utility and protecting sensitive information.
Focus areas:
- Clinical report anonymisation
- Commercially Confidential Information (CCI) protection
- Redaction strategy and implementation
- Risk assessments
- Compliance documentation and reporting
WHO REGULATORY
PATHWAYS
Supporting Global Access Through WHO Procedures
The World Health Organization plays a critical role in enabling access to medicinal products in many regions of the world. WHO procedures often serve as important pathways for global procurement, reliance-based registrations, and access to low- and middle-income countries.
A-REG has practical experience supporting WHO regulatory activities, including dossier preparation, submission execution, Health Authority interactions, and lifecycle management activities. We help clients navigate WHO expectations, coordinate global stakeholders, and align regulatory strategies across multiple regions and agencies.
Focus areas:
- WHO Emergency Use Listing (EUL)
- WHO Prequalification (PQ)
- WHO regulatory submissions
- WHO interactions and meetings
- Global reliance pathways & lifecycle management
VACCINES
Expertise Across the Vaccine Lifecycle
Vaccines require a distinct regulatory approach that combines scientific understanding, strategic planning, and effective engagement with Health Authorities. Regulatory decisions made during development can have long-lasting implications for registration, manufacturing, supply, and lifecycle management.
Drawing on extensive vaccine experience, A-REG supports clients throughout the product lifecycle, from early development and regulatory strategy to registration, post-approval maintenance, and global expansion. We help clients navigate evolving regulatory requirements while maintaining focus on development objectives, timelines, commercial presence on the market and patient access.
Focus areas:
- Vaccine development strategy
- Global regulatory planning
- Health Authority engagement
- Manufacturing and lifecycle changes
- Regulatory submissions
- Reliance and market expansion pathways
ADJUVANTS
Specialized Expertise in Vaccine Adjuvant Development and Regulation
Adjuvants play a critical role in modern vaccine development, influencing immunogenicity, safety profiles, manufacturing strategies, and regulatory requirements. As increasingly sophisticated vaccine technologies emerge, successful development of adjuvanted vaccines requires careful alignment of scientific, quality, clinical, and regulatory considerations.
Regulatory Strategy
for Adjuvanted Vaccines
We support clients in navigating the unique regulatory challenges associated with adjuvant-containing vaccines. From development planning and Health Authority interactions to submission strategy and lifecycle management, we help ensure regulatory expectations are considered throughout the product journey.
Novel Excipients and Regulatory
Considerations
Adjuvants play a critical role in modern vaccine development, influencing immunogenicity, safety profiles, manufacturing strategies, and regulatory requirements. As increasingly sophisticated vaccine technologies emerge, successful development of adjuvanted vaccines requires careful alignment of scientific, quality, clinical, and regulatory considerations.
Building Robust Vaccine
Platforms
Adjuvants play a critical role in modern vaccine development, influencing immunogenicity, safety profiles, manufacturing strategies, and regulatory requirements. As increasingly sophisticated vaccine technologies emerge, successful development of adjuvanted vaccines requires careful alignment of scientific, quality, clinical, and regulatory considerations.
Focus areas:
- Adjuvant & adjuvant-antigen development strategy support
- Novel excipient regulatory considerations
- Health Authority interactions
- Regulatory pathway planning
- Quality and CMC considerations
- Clinical development support
- Platform and lifecycle strategy
- Lifecycle management for adjuvanted vaccines
REGULATORY WRITING & DOCUMENTATION
Translating Science and Strategy into Regulatory Documentation
High-quality regulatory documentation is more than a submission requirement. It is a critical tool for communicating product data, regulatory strategy, and scientific justification to Health Authorities.
A-REG supports clients in the preparation, review, and optimisation of regulatory documents throughout the product lifecycle. Combining scientific understanding, regulatory expertise, and practical experience, we help ensure that documentation is clear, consistent, compliant, and aligned with both regulatory expectations and project objectives.
Authoring Regulatory Documents
We support the development of regulatory documents across various submission types and lifecycle stages. From administrative documentation to complex quality, clinical, and non-clinical content, we help clients prepare documentation that effectively communicates their product story and supports regulatory decision-making.
Focus areas:
- Module 1 administrative documents, including Assessor’s Guide, justifications and data overviews
- Labelling & related documents
- Regulatory justifications and position papers
- Non-standard regulatory request documents, special permits, statements, memos, life cycle management documentation, etc.
- Health Authority briefing packages
- Pre-submission documents (PIP/PSP, DSURs, etc.)
- CTD documentation (Module 2 overviews and summaries, CMC documentation and Module 3, etc.)
- SOPs, working instructions, expert articles and overviews
Document Review & Optimisation
Regulatory success often depends as much on document quality as on the underlying data.
We review existing documentation to identify gaps, inconsistencies, areas of regulatory risk, and opportunities for improvement before submission or Health Authority interactions.
Our reviews combine technical accuracy with a focus on strategic messaging, clarity, and alignment across the submission package.
Focus areas:
- Gap assessments, risks identifications and mitigation suggestions
- Technical and regulatory review
- Consistency checks
- Submission readiness reviews
- Health Authority response support
- Quality improvement recommendations
Supporting Regulatory Programs
Documentation rarely exists in isolation. Regulatory documents form part of a broader development, registration, or lifecycle strategy.
We work closely with clients and cross-functional teams to ensure documentation remains aligned with program objectives, regulatory commitments, and evolving project needs. Whether supporting a single document or a complex global program, we provide practical expertise throughout the process.
Focus areas:
- Cross-functional coordination
- Submission planning support
- Regulatory communication materials
- Strategic document development
- Global submission programs
- Post-approval documentation
Why Choose Us?
Expertise
Deep experience across regulatory strategy, Health Authority interactions, submissions, and lifecycle management.
Pragmatism
Clear, practical solutions focused on achieving client’s regulatory and business objectives.
Partnership
Flexible support tailored to the needs, structure, and goals of each organisation.